HDL Elevation and Lipid Lowering Therapy: Current Scenario and Future Perspectives

Publisher： Bentham Science Publishers

E-ISSN： 2212-3962|2|3|214-227

ISSN： 1574-8901

Source： Recent Patents on Cardiovascular Drug Discovery, Vol.2, Iss.3, 2007-11, pp. : 214-227

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HDL inflammation and atherosclerosis: current and future perspectives

By Sampietro Tiziana   Bigazzi Federico   Puntoni Mariarita   Bionda Alberto  

Future Cardiology, Vol. 2, Iss. 1, 2006-01 ,pp. : 37-48

Future Medicine

Access to resources Recommend Favorite

Local ablation therapy for hepatocellular carcinoma: current status and future perspectives

By Kudo Masatoshi  

Journal of Gastroenterology, Vol. 39, Iss. 3, 2004-03 ,pp. : 205-214

Springer Publishing Company

Access to resources Recommend Favorite

Molecular targeted therapy for advanced hepatocellular carcinoma: current status and future perspectives

By Shen Ying-Chun   Hsu Chiun   Cheng Ann-Lii  

Journal of Gastroenterology, Vol. 45, Iss. 8, 2010-08 ,pp. : 794-807

Springer Publishing Company

Access to resources Recommend Favorite

Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma

By  

Digestion, Vol. 96, Iss. 1, 2017-06 ,pp. : 1-4

Karger

Access to resources Recommend Favorite

Cardiovascular prevention with lipid-lowering therapy in elderly

By Philippe F.  

Annales de Cardiologie et d'Angeiologie, Vol. 52, Iss. 4, 2003-08 ,pp. : 246-253

Elsevier

Access to resources Recommend Favorite